Researchers at UCLA have developed a powerful new weapon in the battle against kidney cancer. Instead of relying on ...

UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with built-in weapons to attack kidney cancer tumors and reprogram their protective ...

A gut microbe molecule drives diabetic kidney scarring. Blocking it may offer new treatment options. A new study from the ...

PD-1 blocking treatment may convert TAMs from tumor-promoting to tumor-fighting, improving outcomes in metastatic clear cell kidney cancer. Higher levels of CD163-positive TAMs are linked to better ...

Enabling patients to generate CAR T-cells internally could cut kidney cancer therapy costs, explained Dr. Wayne Marasco of Dana-Farber Cancer Institute. In vivo CAR T-cell therapy could drastically ...

A study provides new insight into how damaged cells interact within disease-promoting microenvironments following acute kidney injury, or AKI. Researchers used a cutting-edge tool, called seqFISH, ...